GLP-1 Medications for Weight Loss: The Complete 2026 Guide

GLP-1 receptor agonists have transformed obesity medicine. Originally developed for type 2 diabetes, these medications are now the most effective pharmaceutical intervention for chronic weight management - surpassing decades of failed diet drugs, appetite suppressants, and surgical alternatives for many patients.

But the landscape is evolving fast. Dual-agonist formulations targeting both GLP-1 and GIP receptors are showing significantly better results than first-generation options. Here's what you need to know in 2026.

What are GLP-1 medications?

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a naturally occurring gut hormone that regulates appetite and blood sugar. When you eat, your body releases GLP-1, which signals fullness to the brain and slows stomach emptying. These medications amplify that signal - dramatically reducing hunger, cravings, and what patients call "food noise."

The current generation of GLP-1 medications includes:

• Semaglutide (Wegovy, Ozempic) - GLP-1 only, once-weekly injection
• Liraglutide (Saxenda) - GLP-1 only, daily injection
• Tirzepatide (Zepbound, Mounjaro) - Dual GLP-1/GIP, once-weekly injection

How much weight can you lose?

Weight loss varies by medication and individual factors, but clinical trial data provides a clear hierarchy:

For context: a 180-pound woman on a dual-agonist protocol could expect to lose approximately 40 pounds over the course of treatment.

Side effects: what to actually expect

The most common side effect is nausea, especially during the first 2-4 weeks as your body adjusts. However, nausea rates vary dramatically by medication:

• Semaglutide (Wegovy/Ozempic): ~44% experience nausea
• Dual GLP-1/GIP agonists: ~8% experience nausea (with optimized titration)

Other potential side effects include decreased appetite (which is partly the point), mild injection site reactions, and temporary GI changes. Serious side effects are rare but include pancreatitis, gallbladder problems, and - importantly - these medications are contraindicated for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome.

Who qualifies?

GLP-1 medications are typically prescribed for adults with:

• BMI ≥30 (obesity), or
• BMI ≥27 (overweight) with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea)

A physician evaluation is required. The screening process assesses your medical history, current medications, and weight loss goals to determine if treatment is clinically appropriate.

Cost: why are GLP-1s so expensive?

Brand-name GLP-1 medications at retail pharmacies typically cost $800-$1,349 per month. Pharmacy markups, manufacturer pricing, and middlemen all contribute to these high costs.

Telehealth platforms like Linux Health have changed this equation. By eliminating pharmacy middlemen and working directly with licensed pharmacies, monthly costs can drop to $104.99-$139.99 - with physician oversight, supplies, and shipping included.

The bottom line

GLP-1 medications represent a genuine breakthrough in obesity medicine. The data is clear, the side effect profile is manageable, and access is improving. If you've struggled with weight loss through diet and exercise alone, a physician evaluation is worth pursuing.

This article is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.